tiprankstipranks
Cantor Fitzgerald healthcare analyst holds an analyst/industry conference call
PremiumThe FlyCantor Fitzgerald healthcare analyst holds an analyst/industry conference call
23d ago
ARS Pharmaceuticals showcases intranasal epinephrine data at ACAAI meeting
Premium
The Fly
ARS Pharmaceuticals showcases intranasal epinephrine data at ACAAI meeting
29d ago
ARS Pharmaceuticals announces U.S. availability of neffy
Premium
The Fly
ARS Pharmaceuticals announces U.S. availability of neffy
2M ago
Vornado upgraded, JPMorgan downgraded: Wall Street’s top analyst calls
PremiumThe FlyVornado upgraded, JPMorgan downgraded: Wall Street’s top analyst calls
3M ago
Cantor starts ARS at Overweight, sees 111% potential upside
Premium
The Fly
Cantor starts ARS at Overweight, sees 111% potential upside
3M ago
ARS Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
ARS Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
3M ago
ARS Pharmaceuticals upgraded to Strong Buy from Outperform at Raymond James
PremiumThe FlyARS Pharmaceuticals upgraded to Strong Buy from Outperform at Raymond James
3M ago
ARS Pharmaceuticals price target raised to $20 from $19 at Leerink
Premium
The Fly
ARS Pharmaceuticals price target raised to $20 from $19 at Leerink
3M ago
Aquestive Therapeutics price target raised to $15 from $13 at Oppenheimer
Premium
The Fly
Aquestive Therapeutics price target raised to $15 from $13 at Oppenheimer
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100